The AKTQ79K mutation, for instance, was identified in a single BRAF inhibitor-resistant melanoma and was shown to selectively promote BRAF inhibitor resistance in PTEN-wild type melanoma cells that display weak AKT phosphorylation in response to BRAF inhibition25. The gene discussed is BRAF; the disease is melanoma.